TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD

查看最新文献

280

TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD - 最新文献

Safety, Tolerability and Pharmacokinetics/Pharmacodynamic Assessment of an Oral, Selective Prolyl-tRNA Synthetase Inhibitor, DWN12088, for the Treatment of Idiopathic Pulmonary Fibrosis in Healthy Subjects

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1897 M. Park, J. Heo, Y. Kim, J. Han, D.-W. Kim, C. Lee, M. Cho, J. Park

Accuracy of the GAP Score in IPF Patients Treated with Antifibrotic Therapy

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1900 J. Pastre, S. Valery, A. Brown, O. Shlobin, K. Ahmad, V. Khangoora, S. Aryal, C. King, S. Nathan

Antifibrotic Therapy in Fibrosing Interstitial Lung Disease: A Retrospective Analysis at a Tertiary Referral Institution

Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1908 Vikas S. Koppurapu, Y. Zemkova, D. Barber, K. Shin, A. Laroia, C. Lee, K. Ussavarungsi

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。